Foresee Pharmaceuticals Announces Submission of NDA for FDA Approval of LMIS 50 mg

Foresee Pharmaceuticals Co., Ltd. (6576.TWO) (“Foresee”), announced today that it has submitted to the U.S. Food and …
( read original story …)

---